FIELD: chemistry.
SUBSTANCE: invention relates to tetra(pyren-1-yl)tetracyanoporphyrazine, represented by structural formula, where R=C16H9 (pyren-1-yl).
EFFECT: novel compound which can be used in medicine as a multifunctional agent for photodynamic therapy of malignant growths, namely as a photosensitizer and simultaneously as an optical sensor of intracellular viscosity.
1 cl, 4 dwg, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
TETRA(BENZOTHIOPHEN-2-YL)TETRACYANOPORPHYRAZINE AS MULTIMODAL PHOTODYNAMIC THERAPY AGENT | 2018 |
|
RU2684623C1 |
CYANOPORPHYRIN FREE BASE AND ITS USE | 2017 |
|
RU2665471C1 |
PORPHYRAZINE, GADOLINIUS PORPHYRAZINE COMPLEX AND THEIR APPLICATION | 2016 |
|
RU2621710C1 |
METHOD OF PHOTODYNAMIC THERAPY WITH EFFICIENCY CONTROL IN REAL TIME MODE | 2017 |
|
RU2672806C1 |
METHOD FOR ASSESSING THE CONTENT OF HYDROGEN PEROXIDE IN TUMOR CELLS IN PHOTODYNAMIC EXPOSURE | 2018 |
|
RU2700421C1 |
PHOTOSENSITISERS FOR PHOTODYNAMIC THERAPY | 2012 |
|
RU2476218C1 |
PHOTOSENSITISER FOR PHOTODYNAMIC THERAPY | 2013 |
|
RU2549953C2 |
DERIVATIVE OF ZINC METAL COMPLEX CHLORINE-e AND USE THEREOF | 2018 |
|
RU2691754C1 |
PHOTOSENSITISER FOR PHOTODYNAMIC THERAPY | 2012 |
|
RU2479585C1 |
PHOTOSENSIBILE ON THE BASIS OF SEMICONDUCTOR QUANTUM POINTS AND CHLORINE E6 | 2015 |
|
RU2629390C2 |
Authors
Dates
2020-07-03—Published
2019-12-11—Filed